Suppr超能文献

无关的HLA匹配骨髓供者的鉴定:与混合淋巴细胞培养反应相比,HLAⅡ类的限制性片段长度多态性分析、寡核苷酸分型及PCR指纹分析

Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.

作者信息

Mazzola G, el-Borai M H, Berrino M, Cornaglia M, Amoroso A

机构信息

Transplant Immunology Service, San Giovanni Hospital, Turin, Italy.

出版信息

Bone Marrow Transplant. 1993;11 Suppl 1:24-7.

PMID:8095414
Abstract

22 patients awaiting bone marrow transplantation (BMT) and 65 unrelated healthy HLA-A, B and DR serologically identical donors were studied. 21 patients were non reactive on mixed lymphocyte culture (MLC) towards at least one BMT donor, resulting in 32 pairs MLC-negative. 33 other HLA-matched donors gave proliferative responses on MLC. The phenotype DR3/DR7 was significantly higher in patients (P) and donors (D) studied (p < 0.00001). P and D pairs were DNA typed by RFLP analysis for DRB, DQA and DQB genes, and DNA matched by PCR Fingerprinting (PCRF) for DRB, DQA, DQB and DPB. Six patients and 18 donors were also oligotyped for the subtypes of DR1, DR3, DR4 and DR5. Patients and donors were divided according to identity on RFLP, PCRF and responsiveness on MLC, represented by RRI. In the group of MLC non responder pairs, 11% had differences on DRB PCRF compared to 57% in the group of MLC responders (p = 0.0002). The mean RRI value of PCRF DRB incompatible pairs was significantly higher compared to RRI of compatible pairs (p = 0.012). With respect to PCRF for DPB, 75% of MLC-ve pairs were different. Also the mean RRI value was significantly lower in DPB identical pairs compared to non identical ones (p = 0.048). The compatibility between P/D pairs assessed by oligotyping was in accordance with DRB PCRF. PCRF for DQB, but not for DQA, corresponded to MLC responses. Our findings confirm that PCRF offers a precise and fast alternative in DNA matching for DRB. We also suggest that PCRF for DQB and DPB, together with DRB, could eventually substitute MLC.

摘要

对22例等待骨髓移植(BMT)的患者和65名血清学上HLA - A、B和DR相同的无关健康供者进行了研究。21例患者对至少一名BMT供者的混合淋巴细胞培养(MLC)无反应,形成了32对MLC阴性。另外33名HLA匹配的供者在MLC上有增殖反应。所研究的患者(P)和供者(D)中DR3/DR7表型显著更高(p < 0.00001)。通过RFLP分析对P和D对进行DRB、DQA和DQB基因的DNA分型,并通过PCR指纹图谱(PCRF)对DRB、DQA、DQB和DPB进行DNA匹配。6例患者和18名供者还对DR1、DR3、DR4和DR5的亚型进行了寡分型。根据RFLP、PCRF上的一致性以及MLC上的反应性(以RRI表示)对患者和供者进行划分。在MLC无反应对组中,11%在DRB PCRF上存在差异,而MLC有反应组中这一比例为57%(p = 0.0002)。PCRF DRB不匹配对的平均RRI值显著高于匹配对的RRI值(p = 0.012)。关于DPB的PCRF,75%的MLC阴性对存在差异。同样,DPB相同对的平均RRI值显著低于不相同对(p = 0.048)。通过寡分型评估的P/D对之间的相容性与DRB PCRF一致。DQB的PCRF与MLC反应相对应,但DQA的PCRF不对应。我们的研究结果证实,PCRF在DRB的DNA匹配中提供了一种精确且快速的替代方法。我们还建议,DQB和DPB的PCRF与DRB一起最终可能替代MLC。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验